Elevated lipids increased rates of obstetrical and cardiovascular adverse events over a 5-year follow-up period.

High-profile mistakes have led to a loss in donor confidence. Experts say the system needs modernizing, not abandonment.

There’s a need in secondary prevention for personalized risk estimates to motivate patients and guide care, researchers say.

Polypills for HFrEF are being tested in RCTs, and if they’re approved, experts want to be ready for their rollout and use.

Doctors might feel out of their element making the videos, but patients respond to the short, informative reels.

Large-bore devices and longer time on support each up the risk. A study author calls for awareness, not alarm.

Even limited use of veins appears to diminish the long-term benefits of an all-arterial approach,” says Alistair Royse.

Data from implantable monitors show a low AF burden with time, leading some to question the need for oral anticoagulation.

October 9, 2025 | Juan Granada speaks with Marc Dweck for insights on potential pharmacologic therapies that can impact the progression of aortic stenosis. Receive the the latest news, research, and ...